+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cystinuria Market by Treatment Type, Drug Class, Product Type, Distribution Channel, End User, Route Of Administration, Patient Age Group, Treatment Setting - Global Forecast to 2030- Product Image
Cystinuria Market by Treatment Type, Drug Class, Product Type, Distribution Channel, End User, Route Of Administration, Patient Age Group, Treatment Setting - Global Forecast to 2030- Product Image
Sale

Cystinuria Market by Treatment Type, Drug Class, Product Type, Distribution Channel, End User, Route Of Administration, Patient Age Group, Treatment Setting - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082630
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cystinuria market is undergoing marked transformation, as innovations in diagnosis and management foster expanded opportunities across regions. Companies and investors navigating this space require up-to-date strategic intelligence to respond to evolving therapeutic paradigms, regulatory impacts, and competitive dynamics.

Market Snapshot: Cystinuria Market Growth and Dynamics

The Cystinuria Market grew from USD 106.29 million in 2024 to USD 111.61 million in 2025. It is expected to continue growing at a CAGR of 4.86%, reaching USD 141.37 million by 2030. This reflects increased stakeholder confidence in therapeutic advances, expanding adoption of digital health solutions, and heightened activity from biopharma innovators. Tailored formulations, improved access channels, and evolving models of care are supporting consistent demand worldwide. Senior stakeholders can anticipate an environment characterized by cross-disciplinary partnerships and responsive supply chain strategies.

Scope & Segmentation of the Cystinuria Market

  • Treatment Types: Nonpharmacological strategies including dietary management and fluid therapy; Pharmacological options such as alkalizers and thiol derivatives
  • Drug Classes: Focus on alkalizers and thiol derivatives
  • Product Types: Branded medications and generics
  • Distribution Channels: Hospital, online, and retail pharmacies for varied care settings
  • End Users: Home care, hospitals, and specialty clinics
  • Routes of Administration: Oral and intravenous treatments
  • Patient Age Groups: Adults and pediatric patients
  • Treatment Settings: Inpatient and outpatient modalities
  • Geographic Markets: Americas (U.S., Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (U.K., Germany, France, and others), Asia-Pacific (China, India, Japan, and more).
  • Companies Analyzed: Travere Therapeutics, Inc., Shionogi & Co., Ltd., Cipla Limited, Teva Pharmaceutical Industries Ltd., and additional key regional players

Cystinuria Market Key Takeaways

  • Innovative drug formulations and delivery mechanisms are elevating both patient outcomes and adherence levels, driving more specialized care approaches across key demographics.
  • Collaborative efforts between academia and industry are accelerating the introduction of novel disease-modifying agents, particularly those leveraging personalized medicine frameworks and genetic profiling.
  • Digital health integration, such as real-time urinary parameter monitoring, is shaping clinical decision-making and value propositions for differentiated therapeutics in chronic management.
  • Branded therapies emphasize clinical uniqueness, while generics are gaining traction through affordability, incentivizing manufacturers to refine their go-to-market strategies.
  • Regional growth remains uneven, with mature markets benefitting from structured reimbursement systems, while developing geographies require dynamic access and distribution solutions.
  • Strong competition is prompting lifecycle management strategies, evidenced by extended-release therapies and product combinations aligned with patient support initiatives.

Tariff Impact and Adaptive Strategies

In 2025, new United States tariffs on active pharmaceutical ingredients and excipients created added cost pressures throughout the cystinuria sector. Manufacturers responded by diversifying sourcing and investing in domestic production, reducing future risk and fortifying supply chain stability. Ongoing policy shifts continue to shape procurement and price negotiations, influencing downstream access and market entry timelines.

Methodology & Data Sources

This report utilizes a mixed-methods approach, combining qualitative insights from clinician and payer interviews with quantitative analysis of published literature, trade data, and proprietary segmentation frameworks. Data triangulation and expert validation underpin the reliability and depth of the strategic findings.

Why This Report Matters for Decision-Makers

  • Enables proactive risk mitigation by mapping supply chain dynamics and trade policy impacts.
  • Offers actionable insights for aligning R&D investments with emerging therapeutic opportunities and evolving patient segments.
  • Supports evidence-driven decisions by synthesizing advancements across regional, technological, and end-user landscapes.

Conclusion

This analysis equips senior leaders with clear direction for strategic planning and investment in the cystinuria market. Comprehensive segmentation, tariff impact foresight, and actionable recommendations position organizations to respond confidently to market evolution and competitive change.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cystinuria Market, by Treatment Type
8.1. Introduction
8.2. Nonpharmacological
8.2.1. Dietary Management
8.2.2. Fluid Therapy
8.3. Pharmacological
8.3.1. Alkalizers
8.3.2. Thiol Derivatives
9. Cystinuria Market, by Drug Class
9.1. Introduction
9.2. Alkalizers
9.3. Thiol Derivatives
10. Cystinuria Market, by Product Type
10.1. Introduction
10.2. Branded
10.3. Generic
11. Cystinuria Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Cystinuria Market, by End User
12.1. Introduction
12.2. Home Care Settings
12.3. Hospitals
12.4. Specialty Clinics
13. Cystinuria Market, by Route Of Administration
13.1. Introduction
13.2. Intravenous
13.3. Oral
14. Cystinuria Market, by Patient Age Group
14.1. Introduction
14.2. Adult
14.3. Pediatric
15. Cystinuria Market, by Treatment Setting
15.1. Introduction
15.2. Inpatient
15.3. Outpatient
16. Americas Cystinuria Market
16.1. Introduction
16.2. United States
16.3. Canada
16.4. Mexico
16.5. Brazil
16.6. Argentina
17. Europe, Middle East & Africa Cystinuria Market
17.1. Introduction
17.2. United Kingdom
17.3. Germany
17.4. France
17.5. Russia
17.6. Italy
17.7. Spain
17.8. United Arab Emirates
17.9. Saudi Arabia
17.10. South Africa
17.11. Denmark
17.12. Netherlands
17.13. Qatar
17.14. Finland
17.15. Sweden
17.16. Nigeria
17.17. Egypt
17.18. Turkey
17.19. Israel
17.20. Norway
17.21. Poland
17.22. Switzerland
18. Asia-Pacific Cystinuria Market
18.1. Introduction
18.2. China
18.3. India
18.4. Japan
18.5. Australia
18.6. South Korea
18.7. Indonesia
18.8. Thailand
18.9. Philippines
18.10. Malaysia
18.11. Singapore
18.12. Vietnam
18.13. Taiwan
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. Travere Therapeutics, Inc.
19.3.2. Shionogi & Co., Ltd.
19.3.3. Cipla Limited
19.3.4. Teva Pharmaceutical Industries Ltd.
19.3.5. Sandoz International GmbH
19.3.6. Dr. Reddy’s Laboratories Limited
19.3.7. Alembic Pharmaceuticals Limited
19.3.8. Cadila Healthcare Limited
19.3.9. Sun Pharmaceutical Industries Limited
19.3.10. Glenmark Pharmaceuticals Limited
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. CYSTINURIA MARKET MULTI-CURRENCY
FIGURE 2. CYSTINURIA MARKET MULTI-LANGUAGE
FIGURE 3. CYSTINURIA MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CYSTINURIA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CYSTINURIA MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CYSTINURIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CYSTINURIA MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CYSTINURIA MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 20. GLOBAL CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2024 VS 2030 (%)
FIGURE 22. GLOBAL CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS CYSTINURIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. AMERICAS CYSTINURIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES CYSTINURIA MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 26. UNITED STATES CYSTINURIA MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. CYSTINURIA MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 32. CYSTINURIA MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CYSTINURIA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CYSTINURIA MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CYSTINURIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CYSTINURIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CYSTINURIA MARKET SIZE, BY DIETARY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CYSTINURIA MARKET SIZE, BY FLUID THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CYSTINURIA MARKET SIZE, BY ALKALIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CYSTINURIA MARKET SIZE, BY THIOL DERIVATIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CYSTINURIA MARKET SIZE, BY ALKALIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CYSTINURIA MARKET SIZE, BY THIOL DERIVATIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CYSTINURIA MARKET SIZE, BY BRANDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CYSTINURIA MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CYSTINURIA MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CYSTINURIA MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CYSTINURIA MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CYSTINURIA MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CYSTINURIA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CYSTINURIA MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CYSTINURIA MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CYSTINURIA MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CYSTINURIA MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CYSTINURIA MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CYSTINURIA MARKET SIZE, BY INPATIENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CYSTINURIA MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CYSTINURIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES CYSTINURIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 60. CANADA CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 61. CANADA CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 62. CANADA CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 63. CANADA CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 64. CANADA CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 65. CANADA CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. CANADA CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. CANADA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 68. CANADA CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 69. CANADA CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 70. MEXICO CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 71. MEXICO CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 72. MEXICO CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 73. MEXICO CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 74. MEXICO CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. MEXICO CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. MEXICO CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. MEXICO CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 78. MEXICO CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 79. MEXICO CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 121. GERMANY CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 122. GERMANY CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 123. GERMANY CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 124. GERMANY CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 125. GERMANY CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. GERMANY CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. GERMANY CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. GERMANY CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 129. GERMANY CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 130. GERMANY CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 131. FRANCE CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 132. FRANCE CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 133. FRANCE CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 134. FRANCE CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 135. FRANCE CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. FRANCE CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. FRANCE CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. FRANCE CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 139. FRANCE CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 140. FRANCE CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 141. RUSSIA CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 151. ITALY CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 152. ITALY CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 153. ITALY CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 154. ITALY CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 155. ITALY CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. ITALY CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. ITALY CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. ITALY CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 159. ITALY CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 160. ITALY CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 161. SPAIN CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 162. SPAIN CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 163. SPAIN CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 164. SPAIN CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 165. SPAIN CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 166. SPAIN CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. SPAIN CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. SPAIN CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 169. SPAIN CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 170. SPAIN CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 181. SAUDI ARABIA CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 182. SAUDI ARABIA CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 183. SAUDI ARABIA CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 184. SAUDI ARABIA CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 185. SAUDI ARABIA CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 186. SAUDI ARABIA CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 191. SOUTH AFRICA CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 192. SOUTH AFRICA CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 193. SOUTH AFRICA CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 194. SOUTH AFRICA CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 195. SOUTH AFRICA CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 201. DENMARK CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 202. DENMARK CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 203. DENMARK CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 204. DENMARK CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 205. DENMARK CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 206. DENMARK CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. DENMARK CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. DENMARK CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 209. DENMARK CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 210. DENMARK CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 211. NETHERLANDS CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 212. NETHERLANDS CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 213. NETHERLANDS CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 214. NETHERLANDS CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 215. NETHERLANDS CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 216. NETHERLANDS CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. NETHERLANDS CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. NETHERLANDS CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 219. NETHERLANDS CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 221. QATAR CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 222. QATAR CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 223. QATAR CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 224. QATAR CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 225. QATAR CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. QATAR CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. QATAR CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. QATAR CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 229. QATAR CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 230. QATAR CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 231. FINLAND CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 232. FINLAND CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 233. FINLAND CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 234. FINLAND CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 235. FINLAND CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 236. FINLAND CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. FINLAND CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. FINLAND CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 239. FINLAND CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 240. FINLAND CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 241. SWEDEN CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 242. SWEDEN CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 243. SWEDEN CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 244. SWEDEN CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 245. SWEDEN CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. SWEDEN CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 251. NIGERIA CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 252. NIGERIA CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 253. NIGERIA CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 254. NIGERIA CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 255. NIGERIA CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. NIGERIA CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. NIGERIA CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. NIGERIA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 259. NIGERIA CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 260. NIGERIA CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 261. EGYPT CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 262. EGYPT CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 263. EGYPT CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 264. EGYPT CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 265. EGYPT CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 266. EGYPT CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. EGYPT CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. EGYPT CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 269. EGYPT CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 270. EGYPT CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 271. TURKEY CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 272. TURKEY CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 273. TURKEY CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 274. TURKEY CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 275. TURKEY CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 276. TURKEY CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 277. TURKEY CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. TURKEY CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 279. TURKEY CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 280. TURKEY CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 281. ISRAEL CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 282. ISRAEL CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 283. ISRAEL CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 284. ISRAEL CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 285. ISRAEL CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 286. ISRAEL CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 287. ISRAEL CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. ISRAEL CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 289. ISRAEL CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 290. ISRAEL CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 291. NORWAY CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 292. NORWAY CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 293. NORWAY CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 294. NORWAY CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 295. NORWAY CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 296. NORWAY CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 297. NORWAY CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. NORWAY CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 299. NORWAY CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 300. NORWAY CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 301. POLAND CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 302. POLAND CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 303. POLAND CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 304. POLAND CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 305. POLAND CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 306. POLAND CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 307. POLAND CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. POLAND CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 309. POLAND CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 310. POLAND CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 311. SWITZERLAND CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 312. SWITZERLAND CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 313. SWITZERLAND CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 314. SWITZERLAND CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 315. SWITZERLAND CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 316. SWITZERLAND CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 317. SWITZERLAND CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 318. SWITZERLAND CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 319. SWITZERLAND CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 320. SWITZERLAND CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 321. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 322. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 323. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 324. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 325. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 326. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 327. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 328. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 329. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 330. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 331. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 332. CHINA CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 333. CHINA CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 334. CHINA CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 335. CHINA CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 336. CHINA CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 337. CHINA CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 338. CHINA CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 339. CHINA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 340. CHINA CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 341. CHINA CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 342. INDIA CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 343. INDIA CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 344. INDIA CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 345. INDIA CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 346. INDIA CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 347. INDIA CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 348. INDIA CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 349. INDIA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 350. INDIA CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 351. INDIA CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 352. JAPAN CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 353. JAPAN CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 354. JAPAN CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 355. JAPAN CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 356. JAPAN CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 357. JAPAN CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 358. JAPAN CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 359. JAPAN CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 360. JAPAN CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 361. JAPAN CYSTINURIA MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 362. AUSTRALIA CYSTINURIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 363. AUSTRALIA CYSTINURIA MARKET SIZE, BY NONPHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 364. AUSTRALIA CYSTINURIA MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 365. AUSTRALIA CYSTINURIA MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 366. AUSTRALIA CYSTINURIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 367. AUSTRALIA CYSTINURIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 368. AUSTRALIA CYSTINURIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 369. AUSTRALIA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 370. AUSTRALIA CYSTINURIA MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (US

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cystinuria market report include:
  • Travere Therapeutics, Inc.
  • Shionogi & Co., Ltd.
  • Cipla Limited
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Dr. Reddy’s Laboratories Limited
  • Alembic Pharmaceuticals Limited
  • Cadila Healthcare Limited
  • Sun Pharmaceutical Industries Limited
  • Glenmark Pharmaceuticals Limited

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 111.61 Million
Forecasted Market Value ( USD ) by 2030 $ 141.37 Million
Compound Annual Growth Rate4.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Cystinuria Market Report and Forecast 2025-2034 - Product Image

Cystinuria Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Cystinuria treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Cystinuria treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 180 Pages
  • Global
From
Cystinuria - Pipeline Insight, 2025 - Product Image

Cystinuria - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Cystinuria Epidemiology Forecast 2025-2034 - Product Image

Cystinuria Epidemiology Forecast 2025-2034

  • Report
  • 150 Pages
  • Global
From
Overactive Bladder Treatment Market by Product Type, Therapeutic Class, Distribution Channel, Route of Administration, End User, Treatment Type, Age Group, Gender - Global Forecast to 2030 - Product Image

Overactive Bladder Treatment Market by Product Type, Therapeutic Class, Distribution Channel, Route of Administration, End User, Treatment Type, Age Group, Gender - Global Forecast to 2030

  • Report
  • 193 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.